||Recombinant Mouse Mmp7 (Accession # AAA99983) Met1-Leu264 was produced in Mouse myeloma cell line, NS0-derived.
|Predicted N Terminal:
||Supplied as a 0.2 µm filtered solution in MES, NaCl, CaCl2 and Glycerol.
||Measured by its ability to cleave a fluorogenic peptide substrate Mca-KPLGL-Dpa-AR-NH2 .The specific activity is >900 pmol/min/µg, as measured under the described conditions.
||Recombinant Mouse Mmp7 has a calculated MW of 28 kDa. In SDS-PAGE migrates as 31 kDa, reducing conditions.
||>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).